T80.39XA Other ABO incompatibility reaction due to transfusion of blood or blood products, initial encounter

Name of the Condition

• Other ABO incompatibility reaction due to transfusion of blood or blood products, initial encounter.

Summary

This condition describes an adverse immune reaction resulting from the transfusion of blood or blood products with incompatible ABO antigens, occurring during the initial encounter. It is a serious complication that can lead to hemolysis, organ dysfunction, and systemic effects. The reaction is driven by pre-existing antibodies in the recipient that target antigens on the transfused red blood cells, triggering an immune response.

Causes

ABO incompatibility reactions are caused by the transfusion of blood or blood products that do not match the recipient's ABO blood type. This mismatch leads to the destruction of transfused red blood cells by the recipient's antibodies, resulting in hemolysis. Errors in blood typing, crossmatching, or administration can contribute to this complication.

Risk Factors

• Transfusion of blood products without proper ABO typing or crossmatching
• Emergency transfusions where typing may be delayed
• Human error in blood product labeling or administration
• Use of pooled plasma products with mixed ABO types
• Transfusion of platelets or plasma from donors with incompatible ABO antigens

Symptoms

• Fever, chills, or rigors
• Flank pain or back pain
• Hemoglobinuria (dark urine)
• Hypotension or tachycardia
• Dyspnea or respiratory distress
• Jaundice or pallor
• Nausea, vomiting, or abdominal pain

Diagnosis

Diagnosis involves clinical evaluation of symptoms, laboratory testing to confirm hemolysis (e.g., elevated bilirubin, decreased haptoglobin, hemoglobinuria), and verification of ABO incompatibility through blood typing and crossmatching. Additional tests may include direct antiglobulin testing (Coombs test) to detect antibody-coated red blood cells.

Treatment Options

Treatment focuses on stopping the transfusion immediately, providing supportive care (e.g., fluids, oxygen), and managing hemolysis or organ dysfunction. Interventions may include diuretics for renal protection, vasopressors for hypotension, and monitoring for complications like disseminated intravascular coagulation (DIC).

Prognosis and Follow-Up

Prognosis depends on the severity of the reaction and promptness of treatment. Most patients recover with appropriate care, but severe cases can lead to organ damage or death. Follow-up includes monitoring for delayed complications, repeat blood typing, and evaluation of renal or hepatic function.

Complications

• Acute kidney injury or renal failure
• Disseminated intravascular coagulation (DIC)
• Shock or multi-organ dysfunction
• Severe anemia requiring further transfusion
• Long-term organ damage (e.g., hepatic or renal)

Lifestyle & Prevention

Prevention relies on strict adherence to blood typing, crossmatching, and verification protocols before transfusion. Healthcare providers should ensure accurate labeling, proper storage, and double-checking of blood products to minimize errors. Patients with known antibodies may require specialized blood products.

When to Seek Professional Help

Seek immediate medical attention if symptoms of a transfusion reaction occur, such as fever, chills, pain, or changes in urine color, during or after a blood transfusion. Delayed reactions (e.g., jaundice, fatigue) should also be evaluated promptly.

Tips for Medical Coders

Document the initial encounter, confirmation of ABO incompatibility, and specific symptoms or complications. Ensure the code T80.39XA is used for the initial encounter of an other ABO incompatibility reaction due to transfusion. Include details of the transfusion event, laboratory findings, and clinical management in the record.